(FM) Inmunología
Departamento académico
University of Pittsburgh
Pittsburgh, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Pittsburgh (8)
2024
-
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 3
2019
-
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Cell, Vol. 176, Núm. 1-2, pp. 334-347.e12
-
Metabolic consequences of T-cell costimulation in anticancer immunity
Cancer Immunology Research, Vol. 7, Núm. 10, pp. 1664-1669
2018
-
Perspectives in immunotherapy: Meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1
2016
-
Emerging opportunities and challenges in cancer immunotherapy
Clinical Cancer Research, Vol. 22, Núm. 8, pp. 1845-1855
2015
-
Consensus nomenclature for CD8+ T cell phenotypes in cancer
OncoImmunology, Vol. 4, Núm. 4
-
Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014
Journal of Translational Medicine, Vol. 13, Núm. 1
2014
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508